bioRxiv/medRxiv TRiP Review Activity

412 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 15: Articles 141-150  | Next

Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia
Spinler, K., Hamilton, M., Bajaj, J., Shima, Y., Diaz, E., Kritzik, M., Reya, T.
10.1101/2023.12.29.573601 — Posted: 2023-12-29 — Discussion: 2024-05-10  eLife
STIL overexpression shortens lifespan and reduces tumor formation in mice
Moussa, A. T., Cosenza, M. R., Wohlfromm, T., Brobeil, K., Hill, A., Patrizi, A., Mueller-Decker, K., Holland-Letz, T., Jauch, A., Kraft, B., Kraemer, A.
10.1101/2023.12.04.569842 — Posted: 2023-12-05 — Discussion: 2024-05-10  Review Commons
RAPSYN-Mediated Neddylation of BCR-ABL Alternatively Determines the Fate of Philadelphia Chromosome-positive Leukemia
Zhao, m., Dai, B., Li, X., Zhang, Y., Qiao, C., Qin, Y., Li, Z., Li, Q., Wang, S., Yang, Y., Chen, Y.
10.1101/2023.05.24.542110 — Posted: 2023-05-25 — Discussion: 2024-05-02  eLife
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A. A. I., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., Crowder, K. D., Kent, J. R., Madariaga, M. L. L., Jain, R. K., Beckermann, K. E., Lewis, C. A., Clish, C. B., Muir, A., Rathmell, W. K., Rathmell, J. C., Vander Heiden, M. G.
10.1101/2023.12.24.573250 — Posted: 2023-12-24 — Discussion: 2024-04-30  eLife
Integrative DNA methylation analysis of pediatric brain tumors reveals tumor type-specific developmental trajectories and epigenetic signatures of malignancy
Pekkarinen, M., Nordfors, K., Uusi-Makela, J., Kytola, V., Rauhala, M., Urhonen, H., Hayrynen, S., Afyounian, E., Yli-Harja, O., Zhang, W., Helen, P., Lohi, O., Haapasalo, H., Haapasalo, J., Nykter, M., Kesseli, J., Granberg, K. J.
10.1101/2022.03.14.483566 — Posted: 2022-03-16 — Discussion: 2024-04-27  EMBO Press
mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated non-degradative ubiquitination of eIF4A1
Sun, H., Jiao, D., Zhao, X., Chen, Y., Shi, Q., Lv, Z., Li, Y., Gao, K., Wang, C.
10.1101/2023.09.27.559872 — Posted: 2023-09-29 — Discussion: 2024-04-26  eLife
Internalisation of integrin-bound extracellular matrix modulates invasive carcinoma cell migration
Llanses Martinez, M., Nan, K., Bao, Z., Bacchetti, R., Yuan, S., Tyler, J., Le Guezennec, X., Bard, F. A., Rainero, E.
10.1101/2024.01.11.575153 — Posted: 2024-01-14 — Discussion: 2024-04-25  Review Commons
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Howard, G. C., Wang, J., Rose, K. L., Patel, P., Tsui, T., Florian, A. C., Lorey, S. L., Grieb, B. C., Smith, B. N., Slota, M. J., Reynolds, E. M., Goswami, S., Savona, M. R., Lee, T., Fesik, S. W., Liu, Q., Tansey, W. P.
10.1101/2023.07.26.550648 — Posted: 2023-07-29 — Discussion: 2024-04-09  eLife
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers
Pineda, J. M. B., Bradley, R. K.
10.1101/2023.07.10.548412 — Posted: 2023-07-11 — Discussion: 2024-04-08  eLife
Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms
Alcala, N., Voegele, C., Mangiante, L., Sexton-Oates, A., Clevers, H., Fernandez-Cuesta, L., Dayton, T. L., Foll, M.
10.1101/2023.08.31.555732 — Posted: 2023-09-03 — Discussion: 2024-04-08  GigaScience

Evaluation Sources